Our Expertise

We specialize in representing life sciences companies, universities, and other organizations in the biomedical space before the federal government and associated stakeholders.

We put our team’s collective experience and expertise to work for our clients, enabling them to stand out above the competition. We provide strategic counsel to help you build ever-greater visibility with government and other relevant stakeholders – so you can achieve your goals.

We assist our clients in harnessing the power of the federal government to advance their research and policy objectives.

Unmatched expertise. Specialized skills. Trusted relationships.

Our expertise is based on our experience as staff in:

  • Congress
  • White House
  • Department of Health and Human Services (HHS)
  • Department of Defense (DoD)
  • National Institutes of Health (NIH)
  • Centers for Disease Control and Prevention (CDC)

We also have a cadre of consultants that we can draw on for expertise in almost every field in medicine.

Our coalitions of life science companies are supported by:

  • State and federal legislative review
  • Advocacy outreach
  • Strategic communications
  • Short and long-term goal setting
  • Coordination of fly-ins
  • Relationship building

Our consultants specialize in such areas as:

  • Military medicine
  • Biodefense
  • Cancer research
  • Vaccine development
  • Antimicrobials health policy
  • Diabetes research and treatment
  • Reimbursement policy

Specialized Services

Tens of billions of dollars in government funds and other non-dilutive sources become available each year for research and development, commercialization, and procurement of medical products and services. We help our clients improve their chances of success through strategies tailored specifically for their technology and the targeted entities involved. Specifically, we build a funding strategy that leverages the core funding factors:

• Ability of a company’s technology to serve a perceived need
• Strategic location of a company’s research and manufacturing facilities
• Selection of academic and other partners
• Political and commercial credibility of the organization and its products among public officials